+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome



Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome



JAMA Oncology 4(3): 309-315



Guidelines recommend measuring preoperative carcinoembryonic antigen (CEA) in patients with colon cancer. Although persistently elevated CEA after surgery has been associated with increased risk for metastatic disease, prognostic significance of elevated preoperative CEA that normalized after resection is unknown. To investigate whether patients with elevated preoperative CEA that normalizes after colon cancer resection have a higher risk of recurrence than patients with normal preoperative CEA. This retrospective cohort analysis was conducted at a comprehensive cancer center. Consecutive patients with colon cancer who underwent curative resection for stage I to III colon adenocarcinoma at the center from January 2007 to December 2014 were identified. Patients were grouped into 3 cohorts: normal preoperative CEA, elevated preoperative but normalized postoperative CEA, and elevated preoperative and postoperative CEA. Three-year recurrence-free survival (RFS) and hazard function curves over time were analyzed. A total of 1027 patients (461 [50.4%] male; median [IQR] age, 64 [53-75] years) were identified. Patients with normal preoperative CEA had 7.4% higher 3-year RFS (n = 715 [89.7%]) than the combined cohorts with elevated preoperative CEA (n = 312 [82.3%]) (P = .01) but had RFS similar to that of patients with normalized postoperative CEA (n = 142 [87.9%]) (P = .86). Patients with elevated postoperative CEA had 14.9% lower RFS (n = 57 [74.5%]) than the combined cohorts with normal postoperative CEA (n = 857 [89.4%]) (P = .001). The hazard function of recurrence for elevated postoperative CEA peaked earlier than for the other cohorts. Multivariate analyses confirmed that elevated postoperative CEA (hazard ratio [HR], 2.0; 95% CI, 1.1-3.5), but not normalized postoperative CEA (HR, 0.77; 95% CI, 0.45-1.30), was independently associated with shorter RFS. Elevated preoperative CEA that normalizes after resection is not an indicator of poor prognosis. Routine measurement of postoperative, rather than preoperative, CEA is warranted. Patients with elevated postoperative CEA are at increased risk for recurrence, especially within the first 12 months after surgery.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051064341

Download citation: RISBibTeXText

PMID: 29270608

DOI: 10.1001/jamaoncol.2017.4420


Related references

Preoperative carcinoembryonic antigen as an outcome predictor in colon cancer. Journal of Surgical Oncology 108(1): 14-18, 2013

Value of serum levels of carcinoembryonic antigen and gastrointestinal cancer antigen ca 19 9 for preoperative staging and postoperative monitoring of patients with colorectal carcinoma. Diseases of the Colon & Rectum 28(12): 895-899, 1985

Value of serum levels of carcinoembryonic antigen, CEA, and gastrointestinal cancer antigen, GICA or CA 19-9, for preoperative staging and postoperative monitoring of patients with colorectal carcinoma. Diseases of the Colon and Rectum 28(12): 895-899, 1985

Is decrement ratio between preoperative and postoperative serum carcinoembryonic antigen level considered as a predictive prognostic indicator in colorectal cancer patients?. International Journal of Cancer Supplement (13): 224, 2002

Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer. Annals of Surgical Oncology 24(1): 227-235, 2016

Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen. Annals of Surgical Oncology 19(11): 3422-3431, 2013

Evidence for common and distinct determinants of colon carcinoembryonic antigen, colon carcinoma antigen-III, and molecules with carcinoembryonic antigen activity isolated from breast and ovarian cancer. Cancer Research 37(9): 3100-3108, 1977

PP110-SUN: Onoderas Prognostic Nutritional Index is Associated with Postoperative Survival of Patients Undergoing Surgery for Advanced Gastric Cancer with a Normal Preoperative Serum Level of Carcinoembryonic Antigen. Clinical Nutrition 33: S60-S61, 2014

Relation between Carcinoembryonic Antigen Levels in Colon Cancer Tissue and Serum Carcinoembryonic Antigen Levels at Initial Surgery and Recurrence. Oncology 91(2): 85-89, 2016

Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for Recurrence. Oncology 92(5): 276-282, 2017

Preoperative Serum Carcinoembryonic Antigen as a Marker for Predicting the Outcome of Three Cancers. Biomarkers in Cancer 9: 1-7, 2017

The predictive value of preoperative carcinoembryonic antigen level in the prognosis of colon cancer. American Journal of Surgery 204(4): 447-452, 2012

Prognostic use of preoperative and immediate postoperative carcinoembryonic antigen determinations in colonic cancer. Canadian Journal of Surgery. Journal Canadien de Chirurgie 20(1): 64-67, 1977

Carcinoembryonic antigen (CEA) in colonic cancer. Use in preoperative and postoperative diagnosis and prognosis. JAMA 221(1): 31-35, 1972

Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes. World Journal of Surgical Oncology 16(1): 26-26, 2018